C Tănăsescu is a scholar working on Rheumatology, Hepatology and Epidemiology.
According to data from OpenAlex, C Tănăsescu has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 10 papers in Hepatology and 9 papers in Epidemiology. Recurrent topics in C Tănăsescu's work include Systemic Lupus Erythematosus Research (13 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). C Tănăsescu is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). C Tănăsescu collaborates with scholars based in Romania, United States and Germany. C Tănăsescu's co-authors include Mathew Thomas, Stephen Hall, A Gallacher, Roger A. Levy, Michelle Petri, William W. Freimuth, Z. John Zhong, Joung-Liang Lan, Е. Л. Насонов and Ho‐Youn Kim and has published in prestigious journals such as The Lancet, Gastroenterology and Journal of Hepatology.
In The Last Decade
C Tănăsescu
39 papers
receiving
1.7k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
20111.4k citationsSandra Navarra, Renato Guzmán et al.The Lancetprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of C Tănăsescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Tănăsescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Tănăsescu more than expected).
This network shows the impact of papers produced by C Tănăsescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Tănăsescu. The network helps show where C Tănăsescu may publish in the future.
Co-authorship network of co-authors of C Tănăsescu
This figure shows the co-authorship network connecting the top 25 collaborators of C Tănăsescu.
A scholar is included among the top collaborators of C Tănăsescu based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with C Tănăsescu. C Tănăsescu is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Ilie, Mădălina, et al.. (2012). Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.. PubMed. 70(3). 101–4.2 indexed citations
5.
Predețeanu, Denisa, et al.. (2011). Neuromyelitis optica--complication or comorbidity in primary Sjögren's syndrome?. PubMed. 49(4). 295–300.11 indexed citations
6.
Navarra, Sandra, Renato Guzmán, A Gallacher, et al.. (2011). Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. The Lancet. 377(9767). 721–731.1401 indexed citations breakdown →
7.
Tănăsescu, Radu, et al.. (2011). Hepatitis C virus-mixed cryoglobulinemia-lymphoma relationship.. PubMed. 49(1). 3–10.1 indexed citations
8.
Tănăsescu, C, A. Balanescu, Paul Bălănescu, et al.. (2010). IL-17 in cutaneous lupus erythematosus. European Journal of Internal Medicine. 21(3). 202–207.81 indexed citations
9.
Balanescu, A., Paul Bălănescu, C Tănăsescu, et al.. (2010). Immunohistochemical aspects of apoptosis in subcutaneous lupus erythematosus.. PubMed. 48(3). 261–5.2 indexed citations
10.
Jurcuț, Ciprian, Ruxandra Jurcuţ, Carina Mihai, et al.. (2010). Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis.. PubMed. 48(1). 51–5.10 indexed citations
Hytiroglou, Prodromos, Sabina Zurac, Irinel Popescu, et al.. (2000). Biliary cystadenocarcinoma with two types of tumour cells. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 437(5). 555–559.4 indexed citations
19.
Tănăsescu, C, et al.. (1989). Use of the Romanian product Silimarina in the treatment of chronic liver diseases.. PubMed. 26(4). 311–22.12 indexed citations
20.
Tănăsescu, C, et al.. (1983). The Bucharest multifactorial prevention trial. The changes of morbidity and of general and specific mortality.. PubMed. 20(3). 197–208.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.